𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

✍ Scribed by Vlad Ratziu; Philippe Giral; Sophie Jacqueminet; Fréderic Charlotte; Agnès Hartemann–Heurtier; Lawrence Serfaty; Philippe Podevin; Jean–Marc Lacorte; Carole Bernhardt; Eric Bruckert; André Grimaldi; Thierry Poynard

Book ID
119760374
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
479 KB
Volume
135
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of rosiglitazone in n
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
✍ Vlad Ratziu; Fréderic Charlotte; Carole Bernhardt; Philippe Giral; Marine Halbro 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB 👁 1 views

Short-term trials of glitazones in nonalcoholic steatohepatitis (NASH) yielded controversial histological results. Longer treatment might result in additional improvement. After a 1-year randomized trial, 53 patients underwent a control liver biopsy and were enrolled in an open-label extension trial